Abstract
The screening of large libraries in order to obtain hits for receptors of interest has been the mainstay of drug research for some time now. It is increasingly being recognised that this is a relatively inefficient way to achieve this end and the screening of libraries either designed or selected to hit particular targets is rapidly becoming the method of choice. The advantages in terms of success rate to achieve viable lead series are magnified by the cost and time savings achieved by screening more carefully selected groups of compounds. A number of approaches have been used for the design and production of such libraries or methods for selection of such focused sets from larger diverse collections. These range from combinatorially produced ligand-mimetic approaches through pharmacophore-based design to those methods based on statistical selection techniques. Most recently, progress in chemogenomic approaches has thrown new light on the relationship between receptor sequence and compounds that interact at particular receptors and this is also having an impact on the design of targeted libraries.
Keywords: G-Protein Coupled, chemogenomic
Current Topics in Medicinal Chemistry
Title: The Design of Screening Libraries Targeted at G-Protein Coupled Receptors
Volume: 4 Issue: 6
Author(s): Roger Crossley
Affiliation:
Keywords: G-Protein Coupled, chemogenomic
Abstract: The screening of large libraries in order to obtain hits for receptors of interest has been the mainstay of drug research for some time now. It is increasingly being recognised that this is a relatively inefficient way to achieve this end and the screening of libraries either designed or selected to hit particular targets is rapidly becoming the method of choice. The advantages in terms of success rate to achieve viable lead series are magnified by the cost and time savings achieved by screening more carefully selected groups of compounds. A number of approaches have been used for the design and production of such libraries or methods for selection of such focused sets from larger diverse collections. These range from combinatorially produced ligand-mimetic approaches through pharmacophore-based design to those methods based on statistical selection techniques. Most recently, progress in chemogenomic approaches has thrown new light on the relationship between receptor sequence and compounds that interact at particular receptors and this is also having an impact on the design of targeted libraries.
Export Options
About this article
Cite this article as:
Crossley Roger, The Design of Screening Libraries Targeted at G-Protein Coupled Receptors, Current Topics in Medicinal Chemistry 2004; 4 (6) . https://dx.doi.org/10.2174/1568026043451140
DOI https://dx.doi.org/10.2174/1568026043451140 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacology of the Human Saphenous Vein
Current Vascular Pharmacology Exploring the Management of Statin Intolerant Patients: 2016 and Beyond
Current Vascular Pharmacology Synthetic Oligodeoxynucleotides Containing Deoxycytidyl-Deoxyguanosine Dinucleotides (CpG ODNs) and Modified Analogs as Novel Anticancer Therapeutics
Current Pharmaceutical Design Subcellular Injuries in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Plasma Cytokine Levels in Overweight Versus Obese Disease-Free Perimenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets An Update on Autoinflammatory Diseases
Current Medicinal Chemistry Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?
Current Cancer Drug Targets Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies
Current Medicinal Chemistry Neurotrophic Factor Treatment After Spinal Root Avulsion Injury
Central Nervous System Agents in Medicinal Chemistry Editorial [ Hot Topic: Host Defense Peptide: Roles and Application (Guest Editor: Alessandro Tossi)]
Current Protein & Peptide Science Nucleic Acid Drugs for Preventing Restenosis after Coronary Revascularization
Current Topics in Medicinal Chemistry Information Extraction in the Life Sciences: Perspectives for Medicinal Chemistry, Pharmacology and Toxicology
Current Topics in Medicinal Chemistry Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes
Current Drug Targets Developments in High-Yield System Expressed Vaccines and Immunotherapy
Recent Patents on Biotechnology Mass Spectrometry Imaging: Applications in Drug Distribution Studies
Current Drug Metabolism New Insights into the Intracellular Mechanisms by Which PGI2 Analogues Elicit Vascular Relaxation: Cyclic AMP-Independent, Gs-Protein Mediated-Activation of MaxiK Channel
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Bisphosphonate Anticancer Activity in Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Novel Therapies in OA
Current Drug Targets Regulation of Cys-Based Protein Tyrosine Phosphatases Via Reactive Oxygen and Nitrogen Species in Mast Cells and Basophils
Current Medicinal Chemistry The Heme Oxygenase System and Type-1 Diabetes
Current Pharmaceutical Design